OP0108 DUAL NEUTRALISATION OF IL-17A AND IL-17F WITH BIMEKIZUMAB IN PATIENTS WITH ACTIVE PSA: OVERALL AND TNF-INHIBITOR-NAÏVE POPULATION RESULTS FROM A 48-WEEK PHASE 2B RANDOMISED STUDY release_rev_168e368c-1434-4ddb-b6c2-43c604fcf7ca

by Christopher T. Ritchlin, Arthur Kavanaugh, Joseph F. Merola, Georg Schett, Jose U. Scher, Richard B. Warren, Deepak Assudani, Thomas Kumke, Barbara Ink, Iain Mcinnes

Released as a paper-conference by BMJ Publishing Group Ltd and European League Against Rheumatism.

2019  

Type  paper-conference
Stage   unknown
Year   2019
Work Entity
access all versions, variants, and formats of this works (eg, pre-prints)
Revision

This is a specific, static metadata record, not necessarily linked to any current entity in the catalog.

Catalog Record
Revision: 168e368c-1434-4ddb-b6c2-43c604fcf7ca
API URL: JSON